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Oesophageal mesenchymal tumours:
clinicopathological features and absence of
Epstein-Barr virus
King Y Lam
Abstract
Background—Recent studies have sug-
gested that the Epstein-Barr virus (EBV)
is associated with smooth muscle tumours
(leiomyoma and leiomyosarcoma) in pa-
tients with human immunodeficiency
virus and in organ transplant recipients.
Leiomyoma is the most common mensen-
chymal tumour found in the oesophagus.
Aim—To report a single institution
experience on oesophageal mesenchymal
tumours and to determine whether EBV is
associated with these tumours.
Methods—40 sporadic oesophageal mes-
enchymal tumours were studied and their
diagnosis confirmed on pathological re-
view and immunohistochemical studies.
Formalin fixed, paraYn wax embedded
tissues from these tumours were analysed
for EBV using in situ hybridisation for two
messenger RNA (mRNA) probes, EBER
and BamH1 W.
Results—The oesophageal mesenchymal
tumours comprised 36 leiomyomas, two
undiVerentiated stromal tumours, and
two gastrointestinal autonomic nerve tu-
mours (GANTs). Median age of the pa-
tients with leiomyoma (26 men, 10
women) was 62 years (range 30 to 85) and
81% of them had an asymptomatic lesion.
The median longitudinal size was 1.2 cm.
Multiple leiomyomas were seen in 11% of
the patients and calcification was noted in
one tumour. Coexisting squamous cell
carcinoma was found in one third of cases.
The stromal tumours were small, asymp-
tomatic, and located in the lower third of
the oesophagus, while the GANTs were
large, symptomatic, and found in the
upper third of the oesophagus. EBV
mRNAs were not detected in all these
tumours.
Conclusions—The clinicopathological fea-
tures of oesophageal leiomyoma, undiVer-
entiated stromal tumour, and GANT were
diVerent. Some oesophageal leiomyomas
were associated with oesophageal squam-
ous cell carcinomas. EBV is not associated
with sporadic oesophageal mesenchymal
tumours.
(J Clin Pathol 1999;52:758–760)
Keywords: leiomyoma; Epstein-Barr virus; stromal
tumour; autonomic nerve tumour
Recent studies suggest that Epstein-Barr virus
(EBV) is a risk factor for the development of
smooth muscle tumours (leiomyoma or leio-
myosarcoma) in immunocompromised pa-
tients such as those aVected by AIDS and in
organ transplant recipients.1–12 The smooth
muscle tumours are believed to originate from
the clonal expansion of individual smooth
muscle cells infected with EBV. EBV shows
tropism for lymphoid and epithelial cells, not
smooth muscle cells.13 Reactivation of EBV
infection is enhanced during immunosuppres-
sion and this may lead to dissemination of EBV
to tissue that is not normally infected by EBV,
such as smooth muscle.14
Stromal tumours of the gastrointestinal tract
can be broadly defined as mesenchymal
neoplasms originating from the muscle wall of
hollow viscera. Most show total lack or incom-
plete features of smooth muscle or neural
diVerentiation.15 In a minority of cases only,
mainly confined to the oesophagus and rec-
tum, are the tumours composed mainly of
smooth muscle. In the oesophagus, leiomyo-
mas account for more than 50% of benign
oesophageal tumours.16 Nonetheless, the char-
acteristics of oesophageal leiomyomas have
received little attention in published reports.
In this study, the clinicopathological features
of patients with oesophageal mesenchymal
tumours collected over a 15 year period in a
referral centre for oesophageal surgery were
analysed. In addition, the presence of EBV in
these tumours was studied to determine
whether the virus is involved in the pathogen-
esis of sporadic oesophageal mesenchymal
tumours.
Methods
COLLECTION OF DATA
The pathology records from the Queen Mary
Hospital were analysed over a 15 year period
(1983 to 1997) to identify cases with oesopha-
geal mesenchymal tumours. The age, sex, and
clinical presentation of the patients were
recorded, as well as the location and longitudi-
nal extent of the tumours. Histological sections
of these cases were retrieved and reviewed. A
paraYn block was chosen for immunohisto-
chemical studies and in situ hybridisation.
IMMUNOHISTOCHEMICAL STUDIES
Five micron paraYn sections from the paraYn
blocks were deparaYnised and rehydrated.
Immunohistochemical studies were performed
using the avidin-biotin-peroxidase complex
method. Appropriate negative controls (using
buVer solution instead of primary antibodies)
and positive controls from normal tissues were
also used. Antibodies to desmin (monoclonal,
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1:50, microwave pretreated, Dakopatts), actin
(monoclonal, 1:200, Dakopatts), S-100 (poly-
clonal, 1:200, Dakopatts), and vimentin
(monoclonal, 1:20, microwave pretreated, Da-
kopatts) were applied to all cases. Avidin-biotin
complex and diaminobenzidine (DAB) were
used as the detection system. Brown staining
was recorded as positive.
IN SITU HYBRIDISATION
Five micron paraYn sections from the paraYn
blocks were deparaYnised, rehydrated, and
pretreated with proteinase K (Sigma). In situ
hybridisation for EBV encoded RNA (EBER)
and BamHI W was then performed on these
sections. EBER probe is specific for EBER
mRNA transcripts (EBER1 and 2), expressed
in high copy numbers during the latent phase
of the EBV life cycle. The probe is targeted at
the nucleotides 6629 to 7128 of EBV. BamHI
W is a DNA sequence reiterated 11 times
within the EBV viral genome. The probe was
obtained from Kreatech Diagnostic (Amster-
dam). Non-radioactive methods were used, as
described previously.17 Nitro-blue tetrazolium
and 5-bromo-4-chloro-3-indolyphophate (BCIP)
were used as substrate. Cell lines and naso-
pharyngeal carcinoma known to be positive for
EBV were used as positive controls. RNase A
treated serial sections and hybridisation buVer
without probe were used as negative controls.
Sections were counterstained withmethyl green.
The slides were then mounted and examined.
Positive staining was recognised as black colora-
tion at the site of hybridisation.
Results
Forty patients (27 men, 13 women) with
oesophageal mesenchymal tumours were
found. Thirty six patients had leiomyomas, two
with stromal tumours and two with gastro-
intestinal autonomic nerve tumours (GANTs).
The leiomyomas were benign smooth mus-
cle tumours characterised by positive staining
to desmin and actin but negative to S-100.
GANTs were mesenchymal tumours of bor-
derline malignant potential defined by ul-
trastructural and immunohistochemical stud-
ies, as reported in our previous study.18 They
were large (diameter 6.5 cm and 8 cm, respec-
tively), symptomatic, and found in the upper
third of the oesophagus.
Stromal tumours were undiVerentiated mes-
enchymal tumours (positive for vimentin) that
showed no evidence of smooth muscle diVer-
entiation (negative to desmin and actin). The
stromal tumours were found in a 50 year old
man and a 66 year old woman. The tumours
were small (each had a diameter of 0.3 cm),
asymptomatic, and located in the lower third of
the oesophagus.
The GANTs were larger (diameter 6.5 cm
and 8 cm, respectively), symptomatic, and
found in the upper third of the oesophagus.
The median age of the 36 patients with leio-
myomas (26 men, 10 women) was 62 years
(range 30 to 85). Most of these patients were
asymptomatic (81% asymptomatic, n = 29),
while 19% (n = 7) presented with dysphagia.
The patients with asymptomatic tumours were
older than those with symptomatic tumours
(mean age 62 v 48 years, p = 0.02 by
Mann-Whitney U test). The tumours were
often located in the middle third of the
oesophagus (25%, n = 9, in the upper third;
50%, n = 18, in the middle third; 25%, n = 9,
in the lower third).
The median diameter of the leiomyomas was
1.2 cm (range, 0.1 to 7 cm). Symptomatic
tumours were slightly larger than asympto-
matic tumours (mean diameter 3.2 cm v 1.3
cm, p = 0.06 by Mann-Whitney U test). On
histological examination, 75% (n = 27) of the
leiomyomas were derived from the muscle lay-
ers and 25% (n = 9) from the muscularis
mucosae. Multiple leiomyomas were seen in
11% of the patients (four of 36). In three of the
four cases, two leiomyomas were present. The
remaining case had five leiomyomas in the
oesophagus. One of the 36 patients had calcifi-
cation in the leiomyoma (fig 1). Coexisting
squamous cell carcinoma of the oesophagus
was found in 12 patients.
None of the 40 mesenchymal tumours was
positive for any of the two probes for EBV. The
lymphocytes, oesophageal mucosa, and smooth
muscle were also negative for EBV.On the other
hand, strong signals were observed in the nuclei
of the tumour cells in the control tissues.
Discussion
This series represents one of the largest single
institution experiences of oesophageal mesen-
chymal tumours. In this study, leiomyoma was
the most common mesenchymal tumour noted
in the oesophagus. In addition, four unusual
oesophageal mesenchymal tumours (two
GANTs and two undiVerentiated stromal
tumours) were found. The features of the two
GANTs have been described in our previous
report.18 The diagnosis of undiVerentiated
oesophageal stromal tumours was based on
both morphology and immunohistochemistry.
Although these tumours are common in other
parts of the gastrointestinal tract, they have
never been properly characterised and de-
scribed in the oesophagus. In the present study,
the tumours were found to be small (diameter
Figure 1 Calcification (arrows) noted in oesophageal leiomyoma. (haematoxylin and
eosin, × 81).
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of each around 0.3 cm), asymptomatic, and
located in the lower third of the oesophagus.
On the other hand, the GANTs were large
(diameter 6.5 and 8.0 cm, respectively), symp-
tomatic, and occurred in the upper third of the
oesophagus.
Oesophageal leiomyomas occur in both
sexes, but there is a male preponderance.16
Both multiple leiomyomas and calcification in
an oesophageal leiomyoma are said to be
uncommon. In the present study, the sex ratio
of 2.6 to 1 was similar to that reported in other
studies.16 Calcification was uncommon, being
found in only one case; however, multiple
tumours were seen in 11% of the patients.
The coexistence of leiomyoma and
squamous cell carcinoma in the oesophagus is
uncommon and has been the subject of many
case reports.19 25 26 Less than 30 cases have been
reported in all. In the present study, one third
of the patients with leiomyoma had concurrent
squamous cell carcinomas. The high incidence
of co-occurrence of these two tumours suggests
this is unlikely to be coincidental. One tumour
may create an environment that directly or
indirectly favours the genesis of the second
tumour. For example, oesophageal stenosis
produced by either a leiomyoma or a carci-
noma might induce or promote the formation
of the other tumour.
The close proximity of the oesophagus to the
nasopharynx and the recent detection of EBV
in smooth muscle tumours of immunocompro-
mised patients raise the possibility that EBV
may be involved in the pathogenesis of
oesophageal mesenchymal tumours. In our
previous investigation, EBV was not detected
in 74 oesophageal squamous cell carcinomas
but was noted in a few lymphocytes adjacent to
the tumour epithelia.27 In the current study,
EBV was not detected in 36 oesophageal
leiomyomas and two stromal tumours. Al-
though the two oesophageal GANTs showed
prominent lymphoid infiltrates, EBV was not
noted in the tumour cells and the lymphoid
infiltrates.
EBV has been linked to smooth muscle
tumours in immunocompromised patients.
The smooth muscle tumours developed in
these patients were often located in the liver
and lung and sometimes in spleen and adrenal
gland.1–12 In gastrointestinal tract, these EBV
related smooth muscle tumours have been
reported in stomach and in large and small
intestine. To our knowledge, no such case has
been reported in the oesophagus. This may
imply that oesophageal smooth muscle is
resistant to EBV induced proliferation. The
data in the current study suggest that EBV is
unlikely to be an important aetiological factor
in oesophageal smooth muscle tumours in
immunocompetent individuals. Although it
could be argued that EBV is present at a level
below the detection threshold of in situ
hybridisation, false negative results are unlikely
as two highly sensitive probes to EBV (EBER
and BamH1W) and positive control tissues
were used.
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